INOFEA empowers enzymes.
Enzyme stabilization and protection is INOFEA`s core business. We have developed an innovative and patented platform technology to provide enzymes with a protective shield. We unlock the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technology. This makes your enzymes 10 times more stable and they can be re-used easily. Our highly resistant enzymes support Biocatalysis including bioconjugation, diagnostics (bioanalysis) or can be formulated as active ingredients. Our technology addresses a wide range of biotech applications for the industry and demonstrated substantial benefits to customers in pharma, food processing, specialty chemicals and consumer care.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Hofackerstrasse 40b, Muttenz,basel-Landschaft 4132,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- inofea.com
- HQ
- Muttenz, Basel-Landschaft
Inofea Ag Questions
Inofea Ag's website is inofea.com
Inofea Ag's LinkedIn profile is https://ch.linkedin.com/company/inofea69
Inofea Ag has
15 employees.
View email and phone details for 15
employees at Inofea Ag.
Inofea Ag's industry is
Biotechnology Research
Inofea Ag's top competitors are
Swiss Industrial Biocatalysis Consortium (Sibc),
Anjarium Biosciences Ag,
Versameb Ag,
Orega Biotech,
Lonza,
Livinovea – Life Science Consultancy,
Altamira Therapeutics,
Goodwall,
Perseo Pharma Ag,
Fimmcyte.
Inofea Ag's categories are Biotechnology Research
Inofea Ag's founding year is 2014
